Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel Free IDYA Stock Alerts

IDEAYA Biosciences (IDYA) Short Interest Ratio & Short Volume

IDEAYA Biosciences logo
$28.32 +0.11 (+0.39%)
Closing price 04:00 PM Eastern
Extended Trading
$28.19 -0.13 (-0.47%)
As of 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

IDEAYA Biosciences Short Interest Overview

As of April 30, 2026, IDEAYA Biosciences (IDYA) had a short interest of 11.71 million shares sold short, representing 13.98% of the public float. This marks a 10.80% increase in short interest since the prior report. The short interest ratio (days to cover) is 11.2, meaning it would take 11.2 days of the average trading volume of 909,954 shares to cover all short positions.

Current Short Interest
11,705,770 shares
Previous Short Interest
10,564,351 shares
Change Vs. Previous Month
10.80%
Dollar Volume Sold Short
$340.64 million
Short Interest Ratio
11.2 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
87,860,000 shares
Short Percent of Float
13.98%
Today's Trading Volume
906,894 shares
Average Trading Volume
909,954 shares
Today's Volume Vs. Average
100%
Short Selling IDEAYA Biosciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for IDEAYA Biosciences and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

IDYA Short Interest Over Time

IDYA Days to Cover Over Time

IDYA Percentage of Float Shorted Over Time

IDEAYA Biosciences Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202611,705,770 shares $340.64 million +10.8%14.0%11.18 $29.10
4/15/202610,564,351 shares $339.96 million +8.2%12.3%4.53 $32.18
3/31/20269,761,427 shares $325.25 million +0.4%11.4%9.35 $33.32
3/13/20269,723,966 shares $321.77 million -0.1%11.4%11.38 $33.09
2/27/20269,732,265 shares $313.38 million -2.6%11.4%12.67 $32.20
2/13/20269,995,587 shares $302.57 million +7.3%11.7%11.52 $30.27
1/30/20269,316,949 shares $299.91 million +7.0%10.9%11.59 $32.19
1/15/20268,705,576 shares $313.92 million +5.6%10.2%8.38 $36.06
12/31/20258,247,135 shares $285.10 million +14.2%9.6%9.47 $34.57
12/15/20257,223,004 shares $241.03 million -6.4%8.5%7.49 $33.37
11/28/20257,717,025 shares $272.49 million -3.9%9.0%9.14 $35.31
11/14/20258,033,340 shares $258.19 million +2.2%9.4%8.52 $32.14
10/31/20257,859,556 shares $250.41 million -7.3%9.2%5.71 $31.86
10/15/20258,480,000 shares $240.66 million +1.1%10.5%7 $28.38
9/30/20258,390,000 shares $228.29 million -11.3%10.4%7.4 $27.21
9/15/20259,460,000 shares $232.05 million -6.2%11.7%8.5 $24.53
8/31/202510,090,000 shares $247.71 million +4.6%12.5%9.3 $24.55
8/15/20259,650,000 shares $234.78 million -4.6%12.0%9 $24.33
7/31/202510,120,000 shares $246.42 million -13.8%12.6%8.8 $24.35
7/15/202511,740,000 shares $251.59 million +1.4%14.9%9.6 $21.43
6/30/202511,580,000 shares $243.41 million +2.1%14.7%8.5 $21.02
6/15/202511,340,000 shares $251.52 million +8.0%14.4%8 $22.18
5/31/202510,500,000 shares $210.53 million -1.7%13.3%7.4 $20.05
5/15/202510,680,000 shares $184.87 million -1.8%13.6%8 $17.31
4/30/202510,880,000 shares $219.01 million +2.0%13.5%8.6 $20.13
4/15/202510,670,000 shares $181.18 million +7.2%13.2%9 $16.98
3/31/20259,950,000 shares $162.98 million +0.7%12.3%9.5 $16.38
3/15/20259,880,000 shares $183.57 million +7.5%12.2%10.8 $18.58
2/28/20259,190,000 shares $189.04 million +3.3%11.4%10.3 $20.57
2/15/20258,900,000 shares $186.90 million -7.1%11.0%9.4 $21.00
1/31/20259,580,000 shares $233.27 million -0.9%12.4%10.4 $24.35
1/15/20259,670,000 shares $224.92 million -3.3%12.5%10.6 $23.26
12/31/202410,000,000 shares $257 million +10.1%12.9%11.2 $25.70
12/15/20249,080,000 shares $228.73 million +1.7%11.7%9.8 $25.19
11/30/20248,930,000 shares $244.32 million -11.2%11.6%10 $27.36
11/15/202410,060,000 shares $268.00 million +8.1%13.0%12.1 $26.64
10/31/20249,310,000 shares $262.08 million -3.1%11.9%13.2 $28.15
10/15/20249,610,000 shares $296.18 million -20.5%12.6%13.8 $30.82
9/30/202412,080,000 shares $382.69 million +3.3%15.8%15 $31.68
9/15/202411,700,000 shares $438.28 million +2.5%15.3%13.3 $37.46
SpaceX eyes a 1.75 trillion valuation - here's what to know (Ad)

Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel

See how to get positioned in SpaceX before the announcement goes public
8/31/202411,420,000 shares $451.09 million -1.0%14.9%13.3 $39.50
8/15/202411,540,000 shares $439.79 million -0.9%15.1%11.9 $38.11
7/31/202411,640,000 shares $501.10 million -2.2%15.4%11.5 $43.05
7/15/202411,900,000 shares $492.07 million +1.6%15.9%11.8 $41.35
6/30/202411,710,000 shares $411.14 million +6.1%17.3%12.6 $35.11
6/15/202411,040,000 shares $420.73 million +2.9%16.3%14.6 $38.11
5/31/202410,730,000 shares $392.18 million -3.3%15.9%14.2 $36.55
5/15/202411,090,000 shares $470.66 million +3.8%16.4%15.5 $42.44
4/30/202410,680,000 shares $434.14 million +8.7%16.2%15.2 $40.65
4/15/20249,830,000 shares $408.04 million +4.5%14.9%13.7 $41.51
3/31/20249,410,000 shares $412.91 million +6.7%14.3%10.4 $43.88
3/15/20248,820,000 shares $390.73 million +3.0%13.6%9.6 $44.30
2/29/20248,560,000 shares $382.63 million +2.6%13.2%8.7 $44.70
2/15/20248,340,000 shares $387.31 million +4.1%12.8%8.4 $46.44
1/31/20248,010,000 shares $348.68 million +1.4%12.4%7.9 $43.53
1/15/20247,900,000 shares $313.95 million -5.5%13.0%7.2 $39.74
12/31/20238,360,000 shares $297.45 million -0.4%15.1%9.1 $35.58
12/15/20238,390,000 shares $294.24 million -2.9%15.1%9.3 $35.07
11/30/20238,640,000 shares $271.73 million +2.4%16.1%11.1 $31.45
11/15/20238,440,000 shares $250.33 million +9.0%15.7%11.5 $29.66
10/31/20237,740,000 shares $210.30 million +15.5%14.6%10.7 $27.17
10/15/20236,700,000 shares $167.43 million -10.3%13.7%11.7 $24.99
9/30/20237,470,000 shares $201.54 million +5.2%15.2%15.4 $26.98
9/15/20237,100,000 shares $207.11 million +4.3%14.5%15 $29.17
8/31/20236,810,000 shares $199.94 million +4.5%13.3%13.5 $29.36
8/15/20236,520,000 shares $167.04 million +8.5%12.7%12.5 $25.62
7/31/20236,010,000 shares $134.38 million -1.6%11.9%11.2 $22.36
7/15/20236,110,000 shares $138.51 million +1.5%12.1%8.1 $22.67
6/30/20236,020,000 shares $141.47 million +25.7%12.0%8 $23.50
6/15/20234,790,000 shares $119.46 million +3.7%9.5%6.3 $24.94
5/31/20234,620,000 shares $105.52 million +0.9%9.2%6.6 $22.84
5/15/20234,580,000 shares $99.16 million No Change9.1%7 $21.65
10/31/20224,830,000 shares $81.58 million +0.8%N/A8.8 $16.89
10/15/20224,790,000 shares $74.58 million +12.7%N/A9.3 $15.57
9/30/20224,250,000 shares $63.41 million +17.1%N/A8.8 $14.92
9/15/20223,630,000 shares $42.69 million +4.0%N/A8.5 $11.76
8/31/20223,490,000 shares $34.31 million -1.4%11.5%9.5 $9.83
8/15/20223,540,000 shares $36.11 million -2.5%11.8%10.7 $10.20
7/31/20223,630,000 shares $54.16 million -2.2%12.1%13.2 $14.92
7/15/20223,710,000 shares $57.51 million -2.9%12.4%12.9 $15.50
6/30/20223,820,000 shares $52.72 million -4.7%12.8%12.5 $13.80
6/15/20224,010,000 shares $49.08 million -5.2%13.4%12.9 $12.24
5/31/20224,230,000 shares $47.16 million +0.2%14.1%13.1 $11.15
5/15/20224,220,000 shares $44.18 million +11.6%14.1%11.2 $10.47
4/30/20223,780,000 shares $36.25 million +5.3%12.8%10.1 $9.59
4/15/20223,590,000 shares $38.84 million +0.8%12.2%9.8 $10.82
3/31/20223,560,000 shares $39.84 million -5.8%N/A9.4 $11.19
3/15/20223,780,000 shares $44.94 million +0.3%N/A10.1 $11.89
2/28/20223,770,000 shares $49.76 million -1.6%12.8%10.3 $13.20
2/15/20223,830,000 shares $57.41 million +7.9%13.0%11.8 $14.99
I’m sounding the alarm (Ad)

Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, Amazon, Snap, and Block have done the same. Most assume this is about AI - but investor Porter Stansberry says the real driver runs far deeper. Goldman Sachs estimates 12,400 Americans are being financially harmed every day by this shift, while others grow wealthier. Stansberry - who predicted the internet economy's rise and recommended Amazon, Qualcomm, and Texas Instruments before they were household names - is now releasing a new investigation he calls The Final Displacement.tc pixel

Watch Stansberry's full investigation and see which companies to buy and sell
1/31/20223,550,000 shares $58.82 million +10.9%12.1%11 $16.57
1/15/20223,200,000 shares $57.02 million +10.0%N/A9.9 $17.82
12/31/20212,910,000 shares $68.79 million +17.8%9.3%9.4 $23.64
12/15/20212,470,000 shares $54.56 million -1.6%7.9%7.6 $22.09
11/30/20212,510,000 shares $55.22 million No Change8.0%7.4 $22.00
11/15/20212,510,000 shares $58.66 million +2.5%8.0%7.7 $23.37
10/29/20212,450,000 shares $52.53 million +6.1%7.8%8.1 $21.44
10/15/20212,310,000 shares $53.43 million -11.2%7.4%7.4 $23.13
9/30/20212,600,000 shares $66.27 million +31.3%8.3%8.1 $25.49
9/15/20211,980,000 shares $51.68 million -6.2%6.3%5.7 $26.10
8/31/20212,110,000 shares $49.59 million -7.5%6.8%7.2 $23.50
8/13/20212,280,000 shares $53.44 million -1.3%7.3%9.2 $23.44
7/30/20212,310,000 shares $56.60 million +22.2%7.7%9.7 $24.50
7/15/20211,890,000 shares $35.29 million +24.3%6.6%9 $18.67
6/30/20211,520,000 shares $31.90 million +22.6%5.3%7.3 $20.99
6/15/20211,240,000 shares $27.34 million -1.6%5.0%8.3 $22.05
5/28/20211,260,000 shares $25.39 million +5.9%5.1%7.9 $20.15

IDYA Short Interest - Frequently Asked Questions

Short interest is the volume of IDEAYA Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 11,705,770 shares of IDYA short. 13.98% of IDEAYA Biosciences' shares are currently sold short. Learn More on IDEAYA Biosciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IDYA shares currently have a short interest ratio of 11.2. Learn More on IDEAYA Biosciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.98% of IDEAYA Biosciences' floating shares are currently sold short.

IDEAYA Biosciences saw a increase in short interest in April. As of April 30th, there was short interest totaling 11,705,770 shares, an increase of 10.8% from the previous total of 10,564,351 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

13.98% of IDEAYA Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to IDEAYA Biosciences: Abivax SA Sponsored ADR (3.21%), Praxis Precision Medicines, Inc. (13.92%), Cytokinetics, Incorporated (13.12%), Krystal Biotech, Inc. (12.08%), ImmunityBio, Inc. (43.21%), Nuvalent, Inc. (6.78%), Vaxcyte, Inc. (10.11%), Qiagen N.V. (3.39%), Kymera Therapeutics, Inc. (14.02%), Mirum Pharmaceuticals, Inc. (17.89%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling IDYA is an investing strategy that aims to generate trading profit from IDEAYA Biosciences as its price is falling. IDYA shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for IDEAYA Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IDYA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IDYA, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like IDYA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:IDYA) was last updated on 5/18/2026 by MarketBeat.com Staff.
From Our Partners
They're not telling you how bad this could get
Valuations are stretched to levels seen only a handful of times in the last hundred years — yet most retiremen...
Parkview Capital Group | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Trump Is Eyeing the Biggest Monetary Shift Since Nixon
On August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...
Americas Gold Company | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
A potential unicorn—still pre-IPO
Mode Mobile - the company turning smartphones into EarnPhones - has posted $115M+ in revenue, 3-year growth of...
Mode Mobile | Sponsoredtc pixel
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel